Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Phosphates/blood"'
Publikováno v:
Revista clinica espanola [Rev Clin Esp] 1973 Sep 15; Vol. 130 (5), pp. 403-16.
Publikováno v:
Revista clinica espanola. 130(5)
Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats
Autor:
Anders Nordholm, Marya Morevati, Ewa Lewin, Søren Egstrand, Maria L. Mace, Klaus Olgaard, Eva Gravesen
Publikováno v:
Nordholm, A, Egstrand, S, Gravesen, E, Mace, M L, Morevati, M, Ølgaard, K & Lewin, E 2019, ' Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats ', Pflügers Archiv-European Journal of Physiology, vol. 471, no. 8, pp. 1079-1094 . https://doi.org/10.1007/s00424-019-02291-2
Activin A is a new fascinating player in chronic kidney disease-mineral and bone disorder (CKD-MBD), which is implicated in progressive renal disease, vascular calcification, and osteodystrophy. Plasma activin A rises early in the progression of rena
Autor:
Schreiber, Peter W, Bischoff-Ferrari, Heike A, Boggian, Katia, Bonani, Marco, van Delden, Christian, Enriquez, Natalia, Fehr, Thomas, Garzoni, Christian, Hirsch, Hans H, Hirzel, Cédric, Manuel, Oriol, Meylan, Pascal, Saleh, Lanja, Weisser, Maja, Mueller, Nicolas J, Swiss Transplant Cohort Study
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191167 (2018)
PloS one, vol. 13, no. 1, pp. e0191167
PLOS ONE, Vol. 13, No 1 (2018) P. e0191167
PLoS ONE
Schreiber, Peter W; Bischoff-Ferrari, Heike A; Boggian, Katia; Bonani, Marco; van Delden, Christian; Enriquez, Natalia; Fehr, Thomas; Garzoni, Christian; Hirsch, Hans H; Hirzel, Cédric; Manuel, Oriol; Meylan, Pascal; Saleh, Lanja; Weisser, Maja; Mueller, Nicolas J (2018). Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation. PLoS ONE, 13(1), e0191167. Public Library of Science 10.1371/journal.pone.0191167
PloS one, vol. 13, no. 1, pp. e0191167
PLOS ONE, Vol. 13, No 1 (2018) P. e0191167
PLoS ONE
Schreiber, Peter W; Bischoff-Ferrari, Heike A; Boggian, Katia; Bonani, Marco; van Delden, Christian; Enriquez, Natalia; Fehr, Thomas; Garzoni, Christian; Hirsch, Hans H; Hirzel, Cédric; Manuel, Oriol; Meylan, Pascal; Saleh, Lanja; Weisser, Maja; Mueller, Nicolas J (2018). Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation. PLoS ONE, 13(1), e0191167. Public Library of Science 10.1371/journal.pone.0191167
Bone disease contributes to relevant morbidity after solid organ transplantation. Vitamin D has a crucial role for bone metabolism. Activation of vitamin D depends on the endocrine function of both, liver and kidney. Our study assessed key markers of
Publikováno v:
Pedersen, L, Christensen, L L, Pedersen, S M & Andersen, M 2017, ' Reduction of calprotectin and phosphate during testosterone therapy in aging men : a randomized controlled trial ', Journal of Endocrinological Investigation, vol. 40, no. 5, pp. 529-538 . https://doi.org/10.1007/s40618-016-0597-3
Objectives: To investigate the effect of testosterone treatment on biomarkers calprotectin, fibroblast growth factor 23 (FGF23), soluble Klotho, phosphate, calcium, parathyroid hormone, creatinine and estimated glomerular filtration rate. Design: Ran
Autor:
Klaus Olgaard, Andreas Kjaer, Carsten H. Nielsen, Maria L. Mace, Jacob Hofman-Bang, Ewa Lewin, Eva Gravesen, Anders Nordholm, Keith A. Hruska
Publikováno v:
PLoS ONE
Gravesen, E, Lerche Mace, M, Nordholm, A, Hofman-Bang, J, Hruska, K, Haagen Nielsen, C, Kjær, A, Olgaard, K & Lewin, E 2018, ' Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification ', PLOS ONE, vol. 13, no. 1, e0190820 . https://doi.org/10.1371/journal.pone.0190820
PLoS ONE, Vol 13, Iss 1, p e0190820 (2018)
Gravesen, E, Lerche Mace, M, Nordholm, A, Hofman-Bang, J, Hruska, K, Haagen Nielsen, C, Kjær, A, Olgaard, K & Lewin, E 2018, ' Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification ', PLOS ONE, vol. 13, no. 1, e0190820 . https://doi.org/10.1371/journal.pone.0190820
PLoS ONE, Vol 13, Iss 1, p e0190820 (2018)
Hyperphosphatemia and vascular calcification are frequent complications of chronic renal failure and bone morphogenetic protein 7 (BMP7) has been shown to protect against development of vascular calcification in uremia. The present investigation exam
Autor:
Patrick Ammann, Shizuko Nagao, Yutaka Oiso, Ryosuke Kaneko, Keiko Nishiwaki-Yasuda, Atsushi Suzuki, Mitsuyasu Itoh, Sahoko Sekiguchi, Masumi Hirabayashi, Joseph Caverzasio, Shogo Asano
Publikováno v:
J Bone Miner Metab
Journal of Bone and Mineral Metabolism, Vol. 28, No 2 (2010) pp. 139-148
Journal of Bone and Mineral Metabolism, Vol. 28, No 2 (2010) pp. 139-148
The type III inorganic phosphate (Pi) transporter Pit-1 was previously found to be preferentially expressed in developing long bones. Several studies also described a regulation of its expression in cultured bone cells by osteotropic factors, suggest
Publikováno v:
Calcified Tissue International. 77:348-355
Children and adolescents with the high bone turnover comprise a high risk population for vitamin D insufficiency. A sample of 178 clinically healthy children aged 3 to 18 years who came from public schools and lived in North West of Greece participat
Autor:
Rigas Kalaitzidis, Konstantinos P. Katopodis, Elli Koliousi, Anna Chala, Joanna Theodorou, Lamprini K. Takouli, Kostas C. Siamopoulos
Publikováno v:
Blood Purification. 23:359-364
Background/Aim: We investigated the potential role of the membrane type on phosphate kinetics. Methods: Six patients on dialysis (HD) were studied using modified cellulose (Hemophan), ethylene-vinyl alcohol (EVAL) and polyacrylonitrile (PAN). Total (
Autor:
William G. Goodman
Publikováno v:
Hong Kong Journal of Nephrology. 4(1):22-28
Renal osteodystrophy presents an ongoing challenge for clinicians, despite numerous therapeutic advances in its management. Hyperphosphatemia is found in approximately 70% of patients undergoing regular dialysis, and secondary hyperparathyroidism is